Therefore, we wanted to investigate how reduced MMP-9 expression affects the response of breast cancer cells (MDA-MB-231 and MCF-7) to CP treatment and whether there is a correlation between MMP-9 and CK19. The gene discussed is MMP9; the disease is breast carcinoma.